A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

Among the more concerning findings in the report is that data from more than half of European countries show high resistance to ciprofloxacin in human isolates of Campylobacter jejuni (71.9%) and ...

based on long-established beta-lactam antibiotic cefepime and a new extended-spectrum beta-lactamase inhibitor (BLI) called enmetazobactam, for the treatment of cUTIs in adults, including severe ...

This rate is higher than observed in children treated with a beta-lactamase resistant agent, although the associated risk estimate reached statistical significance (pooled OR: 2.39 [95% CI ...

American researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as extended-spectrum beta-lactamase (ESBL) producing E. coli. Project leader Dr ...

More information: Abstract: In vitro activity of antimicrobial peptide from African catfish against the Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli ...

Recarbrio – which based on established antibiotic combination imipenem/cilastatin with Merck’s new beta-lactamase inhibitor relebactam – has been cleared by the FDA for adults with ...

that may inactivate certain beta-lactamase enzymes. Take with meals. Base dose on amoxicillin component. Due to clavulanic acid component: two 250mg tabs are not equivalent to one 500mg tab.

that may inactivate certain beta-lactamase enzymes. <3months: not recommended. Take with food. Base dose on amoxicillin component. Due to clavulanic acid component, ES-600 is not interchangable ...

Chengdu Tetrahedral Drug Research Co. Ltd. has synthesized bicyclic derivatives acting as β-lactamase (bacterial) inhibitors reported to be useful for the treatment of bacterial infection.